volume 54, issue 4, P375-380 2010
DOI: 10.1590/s0004-27302010000400006
View full text
|
|
Share

Abstract: absTRacT Introduction: Sibutramine has been described as a drug recommended for treatment of obesity, since it has the ability to inhibit the reuptake of serotonin and noradrenaline in the central nervous system, thereby increasing energy expenditure. Objective: Investigate the anxiogenic and anxiolytic effects of acute and chronic treatment with sibutramine in rats submitted to the task of the elevated plus-maze. Methods: Diazepam was used as a positive control for the anxiolytic effect, and the task of the …

Expand abstract